Foerster, Friedrich; Neumann, Helmut
Panintestinal capsule endoscopy in patients with celiac diseaseEUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY. Bd. 33. 2021 S. E1022-E1026
Hollerbach, Anne; Mueller-Calleja, Nadine; Pedrosa, Denise et al.
Pathogenic lipid-binding antiphospholipid antibodies are associated with severity of COVID-19JOURNAL OF THROMBOSIS AND HAEMOSTASIS. Bd. 19. H. 9. 2021 S. 2335-2347
Galle, Peter R.; Finn, Richard S.; Qin, Shukui et al.
Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trialLANCET ONCOLOGY. Bd. 22. H. 7. 2021 S. 991-1001
Hardy, Timothy; Mozes, Ferenc E.; Lee, Jenny et al.
PERFORMANCE OF AGILE 3+AND AGILE 4 FIBROSCAN-BASED TESTS FOR ADVANCED FIBROSIS AND CIRRHOSIS IN INTERNATIONAL COHORTS COMPRISING OVER 2,500 HISTOLOGICALLY CHARACTERISED NAFLD PATIENTSHEPATOLOGY. Bd. 74. 2021 S. 975A-977A
Oh, Do-Youn; de Braud, Filippo; Bridgewater, John et al.
Phase 2/3 study of bintrafusp alfa with gemcitabine plus cisplatin as first-line treatment of biliary tract cancerANNALS OF ONCOLOGY. Bd. 32. 2021 S. S333-S333
Lawitz, Eric J.; Reiberger, Thomas; Schattenberg, Joern M. et al.
PHASE IB STUDY OF THE SOLUBLE GUANYLATE CYCLASE ACTIVATOR BI 685509 IN PATIENTS WITH MILD AND MODERATE HEPATIC IMPAIRMENTHEPATOLOGY. Bd. 74. 2021 S. 1243A-1244A
Moehler, Markus; Dvorkin, Mikhail; Boku, Narikazu et al.
Phase III Trial of Avelumab Maintenance After First-Line Induction Chemotherapy Versus Continuation of Chemotherapy in Patients With Gastric Cancers: Results From JAVELIN Gastric 100JOURNAL OF CLINICAL ONCOLOGY. Bd. 39. H. 9. 2021
Meric-Bernstam, F.; Furuse, J.; Oh, D-Y. et al.
Pooled analysis safety profile of futibatinib in patients with advanced solid tumors, including intrahepatic cholangiocarcinoma (iCCA)ANNALS OF ONCOLOGY. Bd. 32. 2021 S. S378-S378
Gairing, Simon Johannes; Galle, Peter Robert; Schattenberg, Joern M. et al.
Portal Vein Thrombosis Is Associated with an Increased Incidence of Depression and Anxiety DisordersJOURNAL OF CLINICAL MEDICINE. Bd. 10. H. 23. 2021
Triantafyllias, Konstantinos; Cavagna, Lorenzo; Klonowski, Anna et al.
Possible misclassification of cardiovascular risk by SCORE in antisynthetase syndrome: results of the pilot multicenter study RI.CARDARHEUMATOLOGY. Bd. 60. H. 3. 2021 S. 1300-1312
Faustino, Larissa C.; Kahaly, George J.; Frommer, Lara et al.
Precision Medicine in Graves' Disease: CD40 Gene Variants Predict Clinical Response to an Anti-CD40 Monoclonal AntibodyFRONTIERS IN ENDOCRINOLOGY. Bd. 12. 2021
Scheiner, Bernhard; Pomej, Katharina; Kirstein, Martha M. et al.
Predicting the outcome of patients with hepatocellular carcinoma treated with immunotherapy - the CRAFITY scoreWIENER KLINISCHE WOCHENSCHRIFT. Bd. 133. H. SUPPL 5. 2021 S. 179-179
Scheiner, Bernhard; Pomej, Katharina; Kirstein, Martha M. et al.
Predicting the outcome of patients with hepatocellular carcinoma treated with immunotherapy-the CRAFITY scoreJOURNAL OF HEPATOLOGY. Bd. 75. 2021 S. S236-S238
Hoppe, Elena; Lee, Alan Chun Hong; Hoppe, David et al.
Predictive Factors for Changes in Quality of Life after Steroid Treatment for Active Moderate-to-Severe Graves' Orbitopathy: A Prospective TrialEUROPEAN THYROID JOURNAL. Bd. 9. H. 6. 2021 S. 313-320
Biller, Beverly M. K.; Hoybye, Charlotte; Carroll, Paul et al.
Pregnancy outcomes in women receiving growth hormone replacement therapy enrolled in the NordiNet (R) International Outcome Study (IOS) and the American Norditropin (R) Studies: Web-Enabled Research (ANSWER) ProgramPITUITARY. Bd. 24. H. 4. 2021 S. 611-621
Mueller, Lukas; Hahn, Felix; Maehringer-Kunz, Aline et al.
Prevalence and clinical significance of clinically evident portal hypertension in patients with hepatocellular carcinoma undergoing transarterial chemoembolizationUNITED EUROPEAN GASTROENTEROLOGY JOURNAL. Bd. 10. H. 1. 2021 S. 41-53
Michel, Maurice; Wahl, Alica; Andres, Malena et al.
Prevalence of hepatic steatosis and advanced fibrosis in patients living with HIV in GermanyJOURNAL OF HEPATOLOGY. Bd. 75. 2021 S. S560-S560
Michel, Maurice; Wahl, Alisha; Anders, Malena et al.
PREVALENCE OF HEPATIC STEATOSIS, FIBROSIS AND STEATOHEPATITIS IN PEOPLE LIVING WITH HIV IN GERMANYHEPATOLOGY. Bd. 74. 2021 S. 979A-980A
Nagel, Michael; Arslanow, Anita; Nguyen-Tat, Marc et al.
Prevention instead of Aftercare - Structured Early Detection of Liver Fibrosis and Liver Cirrhosis by Screening the General Population with the Help of the SEAL ProgramINTERNIST. Bd. 62. H. SUPPL 2. 2021 S. 154-155
Moehler, M.; Goyal, L.; Meric-Bernstam, F. et al.
Primary results of phase 2 FOENIX-CCA2: the irreversible FGFR1-4 inhibitor futibatinib in intrahepatic cholangiocarcinoma (iCCA) with FGFR2 fusions/rearrangementsONCOLOGY RESEARCH AND TREATMENT. Bd. 44. 2021 S. 222-222
Van Haele, Matthias; Younes, Ramy; Cockell, Simon et al.
Pro-inflammatory hepatic progenitor cell response is associated with progression of human non-alcoholic fatty liver diseaseJOURNAL OF HEPATOLOGY. Bd. 75. 2021 S. S266-S266
Llovet, Josep M.; Singal, Amit G.; Villanueva, Augusto et al.
Prognostic and predictive factors in patients treated with ramucirumab (RAM) with advanced hepatocellular carcinoma (aHCC) and elevated alpha-fetoprotein (AFP): Results from two phase III trials.JOURNAL OF CLINICAL ONCOLOGY. Bd. 39. H. 15. 2021
Mohr, A.; Bodenstein, M.; Sagoschen, I. et al.
Promoting the safe use of continuously infused medicines in adult intensive care patients by standardised concentrationsANASTHESIOLOGIE & INTENSIVMEDIZIN. Bd. 62. 2021 S. 314-322
Labenz, Christian; Labenz, Joachim
Proton Pump Inhibitors in Patients With Liver Cirrhosis: Evidence to Improve Their Battered ReputationAMERICAN JOURNAL OF GASTROENTEROLOGY. Bd. 116. H. 11. 2021 S. 2304-2304
Branchi, Federica; Klingenberg-Noftz, Rolf; Friedrich, Kristina et al.
PuraStat in gastrointestinal bleeding: results of a prospective multicentre observational pilot studySURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES. Bd. 36. H. 5. 2021 S. 2954-2961
Al-Batran, Salah-Eddin; Hofheinz, Ralf-Dieter; Reichart, Alexander et al.
Quality of life and outcome of patients with metastatic pancreatic cancer receiving first-line chemotherapy with nab-paclitaxel and gemcitabine: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registryINTERNATIONAL JOURNAL OF CANCER. Bd. 148. H. 6. 2021 S. 1478-1488
Deltenre, Pierre; Labenz, Christian; Schuchmann, Marcus
Quality of life as a therapeutic objective in the management of hepatic encephalopathy and the potential role of rifaximin-alphaEUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY. Bd. 33. 2021 S. E1032-E1038
Nagel, Michael; Labenz, Christian; Woerns, Marcus-Alexander
Quantification of portal Hypertension using hepatic venous pressure gradient (HVPG) MeasurementGASTROENTEROLOGE. Bd. 16. H. 1. 2021 S. 51-52
Kudo, Masatoshi; Finn, Richard S.; Morimoto, Manabu et al.
Ramucirumab for Patients with Intermediate-Stage Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Results from Two Phase 3 Studies (REACH and REACH-2)LIVER CANCER. Bd. 10. H. 5. 2021 S. 451-460
Kudo, Masatoshi; Ikeda, Masafumi; Galle, Peter R. et al.
Ramucirumab in patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein: Outcomes by treatment-emergent ascitesHEPATOLOGY RESEARCH. Bd. 51. H. 6. 2021 S. 715-721
Galle, Peter R.; Kudo, Masatoshi; Llovet, Josep M. et al.
Ramucirumab in patients with previously treated advanced hepatocellular carcinoma: Impact of liver disease aetiologyLIVER INTERNATIONAL. Bd. 41. H. 11. 2021 S. 2759-2767
Dietz, Julia; Graf, Christiana; Muellhaupt, Beat et al.
RARE HCV GENOTYPES: PREVALENCE AND RESISTANCE-ASSOCIATED SUBSTITUTIONS IN DAA-NAIVE AND DAA-EXPERIENCED PATIENTSHEPATOLOGY. Bd. 74. 2021 S. 599A-600A
van Dijk, Anne-Marieke; Schattenberg, Jorn M.; Holleboom, Adriaan G. et al.
Referral care paths for non-alcoholic fatty liver disease-Gearing up for an ever more prevalent and severe liver diseaseUNITED EUROPEAN GASTROENTEROLOGY JOURNAL. Bd. 9. H. 8. 2021 S. 903-909
Mueller, Lukas; Hahn, Felix; Maehringer-Kunz, Aline et al.
Refining Prognosis in Chemoembolization for Hepatocellular Carcinoma: Immunonutrition and Liver FunctionCANCERS. Bd. 13. H. 16. 2021
Stingl, Julia Verena; Ban, Sol A.; Nagler, Markus et al.
Refractive change over 5 years and associated factors in the Gutenberg Health StudyINVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. Bd. 62. H. 8. 2021
Fuhrmann, Valentin; de Garibay, Aritz Perez Ruiz; Faltlhauser, Andreas et al.
Registry on extracorporeal multiple organ support with the advanced organ support (ADVOS) system 2-year interim analysisMEDICINE. Bd. 100. H. 7. 2021
Iavarone, Massimo; Invernizzi, Federica; Ivanics, Tommy et al.
Regorafenib Efficacy After Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Retrospective StudyLIVER TRANSPLANTATION. Bd. 27. H. 12. 2021 S. 1767-1778
Ascher, Stefanie; Wilms, Eivor; Pontarollo, Giulia et al.
Response by Ascher et al to Letter Regarding Article, "Gut Microbiota Restricts NETosis in Acute Mesenteric Ischemia-Reperfusion Injury"ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. Bd. 41. H. 1. 2021 S. E74-E75
Kahaly, George J.; Bartalena, Luigi
Response to comment by Smith on the 2021 EUGOGO guidelinesEUROPEAN JOURNAL OF ENDOCRINOLOGY. Bd. 185. H. 6. 2021 S. L15-L16
Lang, Hauke; Kloth, Michael; Moehler, Markus et al.
Response to the Comment on "Extended Molecular Profiling Improves Stratification and Prediction of Survival After Resection of Colorectal Liver Metastases''ANNALS OF SURGERY. Bd. 274. H. 6. 2021 S. E714-E714
Kim, Richard D.; Harris, William P.; Sung, Max W. et al.
Results of a phase Ib study of regorafenib (REG) 80 mg/day plus pembrolizumab (PEMBRO) for first-line treatment of advanced hepatocellular carcinoma (HCC).JOURNAL OF CLINICAL ONCOLOGY. Bd. 39. H. 3. 2021
Adenugba, Akinbami; Hornung, Matthias; Weigand, Kilian et al.
Ribavirin Improves NK Cell IFN gamma Response During Sofosbuvir-based DAA Therapy in HCV-infected Liver Transplant RecipientsTRANSPLANTATION. Bd. 105. H. 10. 2021 S. 2226-2238
Kaps, Leonard; Hildebrand, Katharina; Nagel, Michael et al.
Risk factors for poorer health literacy in patients with liver cirrhosisPLOS ONE. Bd. 16. H. 7. 2021
Boedecker, Simone Cosima; Weinmann-Menke, Julia
Role of nutrition in immune-related kidney diseasesNEPHROLOGE. Bd. 16. H. 4. 2021 S. 224-228
Kluge, S.; Janssens, U.; Welte, T. et al.
S2k Guideline - Recommendations for Inpatient Therapy of Patients with COVID-19PNEUMOLOGIE. 2021
Cornberg, Markus; Sandmann, Lisa; Protzer, Ulrike et al.
S3 Guideline of the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS) for the Prophylaxis, Diagnosis and Therapy of Hepatitis B Virus Infection (AWMF Register No. 021-11)ZEITSCHRIFT FUR GASTROENTEROLOGIE. Bd. 59. H. 07. 2021 S. 691-776
Zhu, Andrew X.; Finn, Richard S.; Kang, Yoon-Koo et al.
Serum alpha-fetoprotein and clinical outcomes in patients with advanced hepatocellular carcinoma treated with ramucirumabBRITISH JOURNAL OF CANCER. Bd. 124. H. 8. 2021 S. 1388-1397
Greten, Tim F.; Abou-Alfa, Ghassan K.; Cheng, Ann-Lii et al.
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of hepatocellular carcinomaJOURNAL FOR IMMUNOTHERAPY OF CANCER. Bd. 9. H. 9. 2021
Kremer, Wolfgang M.; Labenz, Christian; Kuchen, Robert et al.
Sonographic assessment of low muscle quantity identifies mortality risk during COVID-19: a prospective single-centre studyJOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE. Bd. 13. H. 1. 2021 S. 169-179
Armandi, Angelo; Labenz, Christian; Werner, Merle Marie et al.
SPLEEN STIFFNESS MEASUREMENT IS A GOOD SURROGATE FOR DETECTING ESOPHAGEAL VARICES IN PATIENTS WITH PORTAL HYPERTENSION.HEPATOLOGY. Bd. 74. 2021 S. 1261A-1262A
George, Augustine; Diana, Tanja; Laengericht, Jan et al.
Stimulatory Thyrotropin Receptor Antibodies Are a Biomarker for Graves' OrbitopathyFRONTIERS IN ENDOCRINOLOGY. Bd. 11. 2021
Sabatini, S.; Gaggini, M.; Allison, M. et al.
Subjects with NASH and diabetes have a more unfavourable metabolic profile compared to NAFL with and without diabetes: results from the EPOS studyDIABETOLOGIA. Bd. 64. H. SUPPL 1. 2021 S. 352-353
Moehler, Markus; Folprecht, Gunnar; Heinemann, Volker et al.
Survival after secondary liver resection in metastatic colorectal cancer: Comparing data of three prospective randomized European trials (LICC, CELIM, FIRE-3)INTERNATIONAL JOURNAL OF CANCER. Bd. 150. H. 8. 2021 S. 1341-1349
Mueller, Lukas; Mahringer-Kunz, Aline; Gairing, Simon Johannes et al.
Survival Prediction in Intrahepatic Cholangiocarcinoma: A Proof of Concept Study Using Artificial Intelligence for Risk AssessmentJOURNAL OF CLINICAL MEDICINE. Bd. 10. H. 10. 2021
Mak, Anne Linde; Lee, Jenny; van Dijk, Anne-Marieke et al.
Systematic Review with Meta-Analysis: Diagnostic Accuracy of Pro-C3 for Hepatic Fibrosis in Patients with Non-Alcoholic Fatty Liver DiseaseBIOMEDICINES. Bd. 9. H. 12. 2021
Boedecker-Lips, Simone Cosima; Weinmann-Menke, Julia
Systemic lupus erythematosus What is new?NEPHROLOGE. Bd. 16. H. 5. 2021 S. 319-330
R Galle, Peter; Dufour, Jean-Francois; Peck-Radosavljevic, Markus et al.
Systemic therapy of advanced hepatocellular carcinomaFUTURE ONCOLOGY. Bd. 17. H. 10. 2021 S. 1237-1251
Rimassa, Lorenza; Personeni, Nicola; Czauderna, Carolin et al.
Systemic treatment of HCC in special populationsJOURNAL OF HEPATOLOGY. Bd. 74. H. 4. 2021 S. 931-943
Bruix, Jordi; Chan, Stephen L.; Galle, Peter R. et al.
Systemic treatment of hepatocellular carcinoma: An EASL position paperJOURNAL OF HEPATOLOGY. Bd. 75. H. 4. 2021 S. 960-974
Kahaly, George J.; Douglas, Raymond S.; Holt, Robert J. et al.
Teprotumumab for patients with active thyroid eye disease: a pooled data analysis, subgroup analyses, and off-treatment follow-up results from two randomised, double-masked, placebo-controlled, multicentre trialsLANCET DIABETES & ENDOCRINOLOGY. Bd. 9. H. 6. 2021 S. 360-372
Ugradar, Shoaib; Wang, Yao; Mester, Tunde et al.
Teprotumumab for thyroid eye disease: early response is not required for benefitEYE. Bd. 36. H. 7. 2021 S. 1403-1408
Bartalena, L.; Kahaly, G. J.; Baldeschi, L. et al.
The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathyEUROPEAN JOURNAL OF ENDOCRINOLOGY. Bd. 185. H. 4. 2021 S. G43-G67
Gairing, Simon Johannes; Thol, Felix; Mueller, Lukas et al.
The Addition of Transarterial Chemoembolization to Palliative Chemotherapy Extends Survival in Intrahepatic CholangiocarcinomaJOURNAL OF CLINICAL MEDICINE. Bd. 10. H. 12. 2021
Schwarting, Andreas; Friedel, Heiko; Garal-Pantaler, Elena et al.
The Burden of Systemic Lupus Erythematosus in Germany: Incidence, Prevalence, and Healthcare Resource UtilizationRHEUMATOLOGY AND THERAPY. Bd. 8. H. 1. 2021 S. 375-393
Foerster, Friedrich; Galle, Peter Robert
The Current Landscape of Clinical Trials for Systemic Treatment of HCCCANCERS. Bd. 13. H. 8. 2021
Mai, Knut; Fassnacht, Martin; Fuehrer-Sakel, Dagmar et al.
The Diagnosis and Management of Endocrine Side Effects of Immune Checkpoint InhibitorsDEUTSCHES ARZTEBLATT INTERNATIONAL. Bd. 118. H. 23. 2021 S. 389-+
Formes, Henning; Bernardes, Joana P.; Mann, Amrit et al.
The gut microbiota instructs the hepatic endothelial cell transcriptomeISCIENCE. Bd. 24. H. 10. 2021
Romero Gomez, Manuel; Schattenberg, Joern; Shaikh, Anum et al.
The impact of liver fibrosis progression on the Health-related quality of life of patients with non-alcoholic steatohepatitis in clinical practice in EuropeJOURNAL OF HEPATOLOGY. Bd. 75. 2021 S. S399-S399
Maehringer-Kunz, Aline; Steinle, Verena; Kloeckner, Roman et al.
The impact of portal vein tumor thrombosis on survival in patients with hepatocellular carcinoma treated with different therapies: A cohort studyPLOS ONE. Bd. 16. H. 5. 2021
Romero-Gomez, Manuel; Schattenberg, Jorn M.; Kritikou, Persefoni et al.
THE INDIRECT IMPACT OF NON-ALCOHOLIC STEATOHEPATITIS (NASH), BASED ON THE 'GLOBAL ASSESSMENT OF THE IMPACT OF NASH' (GAIN), A SOCIOECONOMIC STUDYHEPATOLOGY. Bd. 74. 2021 S. 1048A-1048A
Erhardtsen, Elisabeth; Rasmussen, Daniel Guldager Kring; Manon-Jensen, Tina et al.
The liver fibrosis marker PRO-C3 increases with fibrosis stage and is neither elevated in diabetics without liver disease nor in healthy obese subjectsJOURNAL OF HEPATOLOGY. Bd. 75. 2021 S. S573-S573
McGlinchey, Aidan; Geng, Dawei; Govaere, Olivier et al.
The Metabolomics of Non-Alcoholic Fatty Liver Disease: Of Networks and BiomarkersJOURNAL OF HEPATOLOGY. Bd. 75. 2021 S. S579-S580
Thimme, R.; Schroeder, J.; Uhlig, J. et al.
The prospective national intersectoral cohort study JADE to study characteristics, treatment and outcome of patients with hepatocellular or cholangiocellular carcinoma in GermanyONCOLOGY RESEARCH AND TREATMENT. Bd. 44. 2021 S. 33-33
Basta, Fabio; Mockel, Tamara; Petersohn, Jan et al.
The relationship between BAFF serum levels, anti-NMDAR autoantibodies and fatigue in patients with systemic lupus erythematosus and multiple sclerosisAUTOIMMUNITY REVIEWS. Bd. 20. H. 5. 2021
Michel, Maurice; Kaps, Leonard; Maderer, Annett et al.
The Role of p53 Dysfunction in Colorectal Cancer and Its Implication for TherapyCANCERS. Bd. 13. H. 10. 2021
Parodis, I.; Adamichou, C.; Aydin, S. et al.
THURSDAY SESSION AbstractsSCANDINAVIAN JOURNAL OF RHEUMATOLOGY. Bd. 50. 2021 S. 1-2
Diana, T.; Ponto, K. A.; Kahaly, G. J.
Thyrotropin receptor antibodies and Graves' orbitopathy (vol 44, pg 703, 2021)JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. Bd. 45. H. 1. 2021 S. 233-233
Das, Arpita; Schattenberg, Jorn M.; Woreta, Tinsay A. et al.
TITLE: EFFECTS OF DIETARY OR SUPPLEMENTAL INTAKE OF FATTY ACIDS ON NON-ALCOHOLIC FATTY LIVER DISEASE: A SYSTEMATIC REVIEWHEPATOLOGY. Bd. 74. 2021 S. 79A-80A
Baumann, Anja; Nier, Anika; Hernandez-Arriaga, Angelica et al.
Toll-like receptor 1 as a possible target in non-alcoholic fatty liver diseaseSCIENTIFIC REPORTS. Bd. 11. H. 1. 2021
Pitton, Michael Bernhard; Weinmann, Arndt; Kloeckner, Roman et al.
Transjugular Portosystemic Stent Shunt: Impact of Right Atrial Pressure on Portal Venous Hemodynamics Within the First WeekCARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY. Bd. 45. H. 1. 2021 S. 102-111
Rinke, Anja; Auernhammer, Christoph J.; Bodei, Lisa et al.
Treatment of advanced gastroenteropancreatic neuroendocrine neoplasia, are we on the way to personalised medicine?GUT. Bd. 70. H. 9. 2021 S. 1768-1781
Luecke, S.; Fottner, C.; Lahner, H. et al.
Treatment outcomes of patients with G3 neuroendocrine neoplasms Data from the German NET RegistryJOURNAL OF NEUROENDOCRINOLOGY. Bd. 33. 2021 S. 72-72
Llovet, Josep M.; Villanueva, Augusto; Marrero, Jorge A. et al.
Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus ConferenceHEPATOLOGY. Bd. 73. 2021 S. 158-191
Gottwald-Hostalek, Ulrike; Kahaly, George J.
Triiodothyronine alongside levothyroxine in the management of hypothyroidism?CURRENT MEDICAL RESEARCH AND OPINION. Bd. 37. H. 12. 2021 S. 2099-2106
Schattenberg, Joern M.; Huber, Yvonne; Kostev, Karel
Tumor Incidence in Patients With Non-Alcoholic Fatty Liver Disease ReplyDEUTSCHES ARZTEBLATT INTERNATIONAL. Bd. 118. H. 15. 2021 S. 271-272
Frommer, Lara; Kahaly, George J.
Type 1 Diabetes and Autoimmune Thyroid Disease-The Genetic LinkFRONTIERS IN ENDOCRINOLOGY. Bd. 12. 2021
El-Khoueiry, Anthony B.; Kim, Richard D.; Harris, William Proctor et al.
Updated results of a phase 1b study of regorafenib (REG) 80 mg/day or 120 mg/day plus pembrolizumab (PEMBRO) for first-line treatment of advanced hepatocellular carcinoma (HCC).JOURNAL OF CLINICAL ONCOLOGY. Bd. 39. H. 15. 2021
Neuberger, Elmo W. I.; Brahmer, Alexandra; Ehlert, Tobias et al.
Validating quantitative PCR assays for cfDNA detection without DNA extraction in exercising SLE patientsSCIENTIFIC REPORTS. Bd. 11. H. 1. 2021
Marczynski, Paul; Meineck, Myriam; Xia, Ning et al.
Vascular Inflammation and Dysfunction in Lupus-Prone Mice-IL-6 as Mediator of Disease InitiationINTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. Bd. 22. H. 5. 2021
Mohr, A; Bodenstein, M; Sagoschen, I et al.
Verordnung und Applikation von Dauerinfusionen in Standardkonzentrationen bei erwachsenen Intensivpatienten. Ein Meilenstein zur Verbesserung der Arzneimitteltherapiesicherheit.Anästh. Intensivmed. H. 62. 2021 S. 314-322
Nettelbeck, Dirk M.; Leber, Mathias F.; Altomonte, Jennifer et al.
Virotherapy in Germany-Recent Activities in Virus Engineering, Preclinical Development, and Clinical StudiesVIRUSES-BASEL. Bd. 13. H. 8. 2021
Kluge, Stefan; Janssens, Uwe; Welte, Tobias et al.
Webinar on Recommendations for inpatient Treatment of Patients with COVID-19-Living GuidelineCHIRURG. Bd. 92. H. 9. 2021 S. 850-850
Hegewald, Janice; Romero Starke, Karla; Garthus-Niegel, Susan et al.
Work-life conflict and cardiovascular health: 5-year follow-up of the Gutenberg Health StudyPLOS ONE. Bd. 16. H. 5. 2021
Banovcin, Peter; Neumann, Helmut
"Pushing" forward deep bile duct cannulationDIGESTIVE AND LIVER DISEASE. Bd. 52. H. 2. 2020 S. 127-129
Maasberg, Sebastian; Bacher, Maria; Rinke, Anja et al.
"Routine Usage of Molecular Targeted Therapies (Everolimus and Sunitinib) and Temozolomide Based Chemotherapy in Neuroendocrine Neoplasia and Its Outcome"ONCOLOGY RESEARCH AND TREATMENT. Bd. 43. 2020 S. 43-44
Eslam, Mohammed; Newsome, Philip N.; Sarin, Shiv K. et al.
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statementJOURNAL OF HEPATOLOGY. Bd. 73. H. 1. 2020 S. 202-209
Kahaly, George J.; Stan, Marius Nicolae; Frommer, Lara et al.
A Novel Anti-CD40 Monoclonal Antibody, Iscalimab, for Control of Graves Hyperthyroidism-A Proof-of-Concept TrialJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. Bd. 105. H. 3. 2020 S. 696-704
Fottner, C.; Apostolidis, L.; Ferrata, M. et al.
A Phase II, Open-Label, Multicenter Trial of Avelumab in Patients with Advanced, Metastatic High Grade Neuroendocrine Carcinomas NEC G3 (WHO 2010) Progressive after First-line Chemotherapy (AVENEC)NEUROENDOCRINOLOGY. Bd. 110. 2020 S. 224-224
Borad, Mitesh J.; Bridgewater, John A.; Morizane, Chigusa et al.
A phase III study of futibatinib (TAS-120) versus gemcitabine-cisplatin (gem-cis) chemotherapy as first-line (1L) treatment for patients (pts) with advanced (adv) cholangiocarcinoma (CCA) harboring fibroblast growth factor receptor 2 (FGFR2) gene rearrangements (FOENIX-CCA3)JOURNAL OF CLINICAL ONCOLOGY. Bd. 38. H. 4. 2020
Eelbode, Tom; Hassan, Cesare; Neumann, Helmut et al.
A PROSPECTIVE MULTI-CENTER VALIDATION STUDY FOR AUTOMATED POLYP DETECTION AS A SECOND OBSERVERGASTROINTESTINAL ENDOSCOPY. Bd. 91. H. 6. 2020 S. AB72-AB72